Artículos por temáticas

Structural abnormalities in early Tourette syndrome children: a combined voxel-based morphometry and tract-based spatial statistics study.

Liu Y, Miao W, Wang J, Gao P, Yin G, Zhang L, Lv C, Ji Z, Yu T, Sabel BA, He H, Peng Y.

PLoS One. 2013 Sep 30;8(9):e76105. doi: 10.1371/journal.pone.0076105.

Tourette syndrome, parenting aggravation, and the contribution of co-occurring conditions among a nationally representative sample.

Robinson LR, Bitsko RH, Schieve LA, Visser SN.

Disabil Health J. 2013 Jan;6(1):26-35. doi: 10.1016/j.dhjo.2012.10.002.

Neuromodulation in Tourette syndrome: dopamine and beyond.

Buse J, Schoenefeld K, Münchau A, Roessner V.

Neurosci Biobehav Rev. 2013 Jul;37(6):1069-84. doi: 10.1016/j.neubiorev.2012.10.004. Review.

Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture.

Davis LK, Yu D, Keenan CL, Gamazon ER, Konkashbaev AI, Derks EM, Neale BM, Yang J, Lee SH, Evans P, Barr CL, Bellodi L, Benarroch F, Berrio GB, Bienvenu OJ, Bloch MH, Blom RM, Bruun RD, Budman CL, Cam

PLoS Genet. 2013 Oct;9(10):e1003864. doi: 10.1371/journal.pgen.1003864.

On being your own worst enemy: an investigation of socially inappropriate symptoms in Tourette syndrome.

Eddy CM, Cavanna AE.

J Psychiatr Res. 2013 Sep;47(9):1259-63. doi: 10.1016/j.jpsychires.2013.05.019.

An introduction to the clinical phenomenology of Tourette syndrome.

Martino D, Madhusudan N, Zis P, Cavanna AE.

Int Rev Neurobiol. 2013;112:1-33. doi: 10.1016/B978-0-12-411546-0.00001-9. Review.

A controlled study of personality and affect in Tourette syndrome.

Eddy CM, Rickards HE, Critchley HD, Cavanna AE.

Compr Psychiatry. 2013 Feb;54(2):105-10. doi: 10.1016/j.comppsych.2012.07.004.

Immune-mediated animal models of Tourette syndrome.

Hornig M, Lipkin WI.

Neurosci Biobehav Rev. 2013 Jul;37(6):1120-38. doi: 10.1016/j.neubiorev.2013.01.007. Review.

Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder.

Denys D, de Vries F, Cath D, Figee M, Vulink N, Veltman DJ, van der Doef TF, Boellaard R, Westenberg H, van Balkom A, Lammertsma AA, van Berckel BN.

Eur Neuropsychopharmacol. 2013 Nov;23(11):1423-31. doi: 10.1016/j.euroneuro.2013.05.012.

Animal models recapitulating the multifactorial origin of Tourette syndrome.

Macrì S, Onori MP, Roessner V, Laviola G.

Int Rev Neurobiol. 2013;112:211-37. doi: 10.1016/B978-0-12-411546-0.00008-1. Review.

Chromosomal rearrangements in Tourette syndrome: implications for identification of candidate susceptibility genes and review of the literature.

Bertelsen B, Debes NM, Hjermind LE, Skov L, Brøndum-Nielsen K, Tümer Z.

Neurogenetics. 2013 Nov;14(3-4):197-203. doi: 10.1007/s10048-013-0372-y.

Clinical pharmacology of comorbid attention deficit hyperactivity disorder in Tourette syndrome.

Rizzo R, Gulisano M.

Int Rev Neurobiol. 2013;112:415-44. doi: 10.1016/B978-0-12-411546-0.00014-7. Review.

Tourette syndrome.

Shahana N, Gilbert DL.

Handb Clin Neurol. 2013;116:631-42. doi: 10.1016/B978-0-444-53497-2.00050-4. Review.

Enhanced antisaccade abilities in children with Tourette syndrome: the Gap-effect Reversal.

Tajik-Parvinchi DJ, Sandor P.

Front Hum Neurosci. 2013 Nov 13;7:768. doi: 10.3389/fnhum.2013.00768.

Preface: the metamorphoses of Gilles de la Tourette syndrome.

Martino D, Cavanna AE.

Int Rev Neurobiol. 2013;112:xv-xx. doi: 10.1016/B978-0-12-411546-0.10000-9. No abstract available.